Showing results (191-200 of 242) with videos related to

Sort By:
Pageof 25
European Urology|July 15, 2026
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer. Part II-2026 Update: Treatment of Relapsing and Metastatic Prostate CancerDerya Tilki, Roderick C N van den Bergh, Erik Briers, et al.
European Urology|September 24, 2023
European Association of Nuclear Medicine Focus 5: Consensus on Molecular Imaging and Theranostics in Prostate CancerDaniela-Elena Oprea-Lager, Steven MacLennan, Anders Bjartell, et al.
European Urology|July 15, 2026
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2026 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative IntentPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
Cell Reports. Medicine|January 27, 2024
Immunomodulatory effects and improved outcomes with cisplatin- versus carboplatin-based chemotherapy plus atezolizumab in urothelial cancerMatthew D Galsky, Xiangnan Guan, Deepali Rishipathak, et al.
European Urology|November 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative IntentNicolas Mottet, Roderick C N van den Bergh, Erik Briers, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 8, 2023
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 TrialEmmanuel S Antonarakis, Se Hoon Park, Jeffrey C Goh, et al.
European Urology|October 22, 2018
Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic ReviewThomas Van den Broeck, Roderick C N van den Bergh, Nicolas Arfi, et al.
European Urology|October 11, 2020
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II-2020 Update: Treatment of Relapsing and Metastatic Prostate CancerPhilip Cornford, Roderick C N van den Bergh, Erik Briers, et al.
The New England Journal of Medicine|August 21, 2024
Belzutifan versus Everolimus for Advanced Renal-Cell CarcinomaToni K Choueiri, Thomas Powles, Katriina Peltola, et al.
European Urology Oncology|December 27, 2023
A Systematic Review of the Efficacy and Toxicity of Brachytherapy Boost Combined with External Beam Radiotherapy for Nonmetastatic Prostate CancerFinbar Slevin, Fabio Zattoni, Enrico Checcucci, et al.
Pageof 25